A number of other equities research analysts have also commented on the stock. ValuEngine lowered shares of CME Group from a buy rating to a hold rating in a report on Wednesday, October 2nd. Citigroup increased their price objective on shares of CME Group from $220.00 to $240.00 and gave the stock a buy rating in a report on Monday, October 21st. JPMorgan Chase & Co. decreased their price objective on shares of CME Group from $183.00 to $173.00 and set an underweight rating on the stock in a report on Friday, December 6th. Credit Suisse Group assumed coverage on shares of CME Group in a report on Monday, December 16th. They set a neutral rating on the stock. Finally, Deutsche Bank increased their price objective on shares of CME Group from $245.00 to $252.00 and gave the stock a buy rating in a report on Thursday, December 19th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of $208.36.
CME opened at $206.86 on Friday. CME Group has a twelve month low of $161.05 and a twelve month high of $224.91. The firm’s 50-day simple moving average is $204.33 and its 200-day simple moving average is $207.20. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market cap of $74.13 billion, a price-to-earnings ratio of 36.36, a PEG ratio of 3.51 and a beta of 0.18.
The firm also recently announced a dividend, which was paid on Wednesday, January 15th. Shareholders of record on Friday, December 27th were given a dividend of $2.50 per share. The ex-dividend date was Thursday, December 26th. This is an increase from CME Group’s previous dividend of $1.75. CME Group’s dividend payout ratio is presently 43.99%.
In other CME Group news, CEO Terrence A. Duffy sold 39,309 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $202.38, for a total transaction of $7,955,355.42. Following the transaction, the chief executive officer now directly owns 46,684 shares in the company, valued at approximately $9,447,907.92. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 1,000 shares of the company’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $201.16, for a total transaction of $201,160.00. Following the transaction, the director now owns 34,905 shares in the company, valued at $7,021,489.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 40,609 shares of company stock worth $8,216,221. Corporate insiders own 1.20% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the business. Evoke Wealth LLC acquired a new position in CME Group during the 3rd quarter valued at about $27,000. Thor Advisors LLC acquired a new stake in shares of CME Group in the 3rd quarter valued at approximately $34,000. Venturi Wealth Management LLC acquired a new stake in shares of CME Group in the 3rd quarter valued at approximately $36,000. Bartlett & Co. LLC raised its position in shares of CME Group by 2,471.4% in the 3rd quarter. Bartlett & Co. LLC now owns 180 shares of the financial services provider’s stock valued at $38,000 after acquiring an additional 173 shares during the period. Finally, Private Capital Group LLC raised its position in shares of CME Group by 44.9% in the 2nd quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 75 shares during the period. Institutional investors own 84.14% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.